Nuclear Receptor Coregulators in Cancer Biology
Open Access
- 28 October 2009
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (21), 8217-8222
- https://doi.org/10.1158/0008-5472.can-09-2223
Abstract
Coregulators (coactivators and corepressors) occupy the driving seat for actions of all nuclear receptors, and consequently, selective receptor modulator drugs. The potency and selectivity for subreactions of transcription reside in the coactivators, and thus, they are critically important for tissue-selective gene function. Each tissue has a “quantitative finger print” of coactivators based on its relative inherited concentrations of these molecules. When the cellular concentration of a coactivator is altered, genetic dysfunction usually leads to a pathologic outcome. For example, many cancers overexpress “growth coactivators.” In this way, the cancer cell can hijack these coactivator molecules to drive proliferation and metastasis. The present review contains summaries of selective coactivators and corepressors that have been demonstrated to play important roles in the malignant process and emphasizes their importance for future therapeutic interventions. [Cancer Res 2009;69(21):8217–22]This publication has 65 references indexed in Scilit:
- Poly(C)-binding proteins as transcriptional regulators of gene expressionBiochemical and Biophysical Research Communications, 2009
- Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formationProceedings of the National Academy of Sciences of the United States of America, 2009
- Essential Phosphatases and a Phospho-Degron Are Critical for Regulation of SRC-3/AIB1 Coactivator Function and TurnoverMolecular Cell, 2008
- Cracking the coregulator codesCurrent Opinion in Cell Biology, 2008
- Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1Proceedings of the National Academy of Sciences of the United States of America, 2007
- Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathwayJournal of Bone and Joint Surgery, 2006
- Absence of the steroid receptor coactivator-3 induces B-cell lymphomaThe EMBO Journal, 2006
- MTA1, a transcriptional activator of breast cancer amplified sequence 3Proceedings of the National Academy of Sciences of the United States of America, 2006
- Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer†Genes, Chromosomes and Cancer, 2002
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997